Structural flexibility of multifunctional HABP1 may be important for regulating its binding to different ligands.
Hyaluronan-binding protein 1 (HABP1)/p32/gC1qR was characterized as a highly acidic and oligomeric protein, which binds to different ligands like hyaluronan, C1q, and mannosylated albumin. It exists as trimer in high ionic and reducing conditions as shown by crystal structure. In the present study, we have examined the structural changes of HABP1 under a wide range of ionic environments. HABP1 exhibits structural plasticity, which is influenced by the ionic environment under in vitro conditions near physiological pH. At low ionic strength HABP1 exists in a highly expanded and loosely held trimeric structure, similar to that of the molten globule-like state, whereas the presence of salt stabilizes the trimeric structure in a more compact fashion. It is likely that the combination of the high net charge asymmetrically distributed along the faces of the molecule and the relatively low intrinsic hydrophobicity of HABP1 result in its expanded structure at neutral pH. Thus, the addition of counter ions in the molecular environment minimizes the intramolecular electrostatic repulsion in HABP1 leading to its stable and compact conformations, which reflect in its differential binding toward different ligands. Whereas the binding of HABP1 toward HA is enhanced on increasing the ionic strength, no significant effect was observed with the two other ligands, C1q and mannosylated albumin. Thus, although HA interacts only with compact HABP1, C1q and mannosylated albumin can bind to loosely held oligomeric HABP1 as well. In other words, structural changes in HABP1 mediated by changes in the ionic environment are responsible for recognizing different ligands.
Jha
Babal Kant
BK
Biochemistry Laboratory, School of Environmental Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Salunke
Dinakar M
DM
Datta
Kasturi
K
D000817:Anilino Naphthalenesulfonates / Q000494:pharmacology; D000818:Animals; D002352:Carrier Proteins; D002850:Chromatography, Gel; D002942:Circular Dichroism; D015922:Complement C1q / Q000737:chemistry; D003432:Cross-Linking Reagents / Q000494:pharmacology; D018360:Crystallography, X-Ray; D019281:Dimerization; D004305:Dose-Response Relationship, Drug; D005456:Fluorescent Dyes / Q000494:pharmacology; D018960:Hyaluronan Receptors / Q000737:chemistry* / Q000502:physiology*; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents / Q000494:pharmacology; D007477:Ions; D008024:Ligands; D008301:Maleimides / Q000494:pharmacology; D024101:Mitochondrial Proteins; D011485:Protein Binding; D011487:Protein Conformation; D011994:Recombinant Proteins / Q000737:chemistry; D012492:Salts / Q000494:pharmacology; D013050:Spectrometry, Fluorescence; D055672:Static Electricity
D000817:Anilino Naphthalenesulfonates; C087299:C1QBP protein, human; D002352:Carrier Proteins; D003432:Cross-Linking Reagents; D005456:Fluorescent Dyes; D018960:Hyaluronan Receptors; D007202:Indicators and Reagents; D007477:Ions; D008024:Ligands; D008301:Maleimides; D024101:Mitochondrial Proteins; D011994:Recombinant Proteins; D012492:Salts; C027132:1-anilino-8-naphthalenesulfonate; C010854:N-(1-anilinonaphthalyl)-4-maleimide; D015922:Complement C1q